171 related articles for article (PubMed ID: 36979711)
1. A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases.
Rada M; Krzywon L; Petrillo S; Lazaris A; Metrakos P
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979711
[TBL] [Abstract][Full Text] [Related]
2. The molecular mechanisms underlying neutrophil infiltration in vessel co-opting colorectal cancer liver metastases.
Rada M; Hassan N; Lazaris A; Metrakos P
Front Oncol; 2022; 12():1004793. PubMed ID: 36330498
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin1 Deficiency in Hepatocytes Affects the Growth of Colorectal Cancer Liver Metastases (CRCLM).
Ibrahim NS; Lazaris A; Rada M; Petrillo SK; Huck L; Hussain S; Ouladan S; Gao ZH; Gregorieff A; Essalmani R; Seidah NG; Metrakos P
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877668
[TBL] [Abstract][Full Text] [Related]
4. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies.
Lazaris A; Amri A; Petrillo SK; Zoroquiain P; Ibrahim N; Salman A; Gao ZH; Vermeulen PB; Metrakos P
J Pathol Clin Res; 2018 Jul; 4(3):184-192. PubMed ID: 29654716
[TBL] [Abstract][Full Text] [Related]
5. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.
Haas G; Fan S; Ghadimi M; De Oliveira T; Conradi LC
Front Cell Dev Biol; 2021; 9():612774. PubMed ID: 33912554
[TBL] [Abstract][Full Text] [Related]
6. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment conditions that favor vessel co-option in colorectal cancer liver metastases: A theoretical model.
Rada M; Lazaris A; Kapelanski-Lamoureux A; Mayer TZ; Metrakos P
Semin Cancer Biol; 2021 Jun; 71():52-64. PubMed ID: 32920126
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3.
Rada M; Kapelanski-Lamoureux A; Tsamchoe M; Petrillo S; Lazaris A; Metrakos P
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626145
[TBL] [Abstract][Full Text] [Related]
10. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
Fleischer JR; Schmitt AM; Haas G; Xu X; Zeisberg EM; Bohnenberger H; Küffer S; Teuwen LA; Karras PJ; Beißbarth T; Bleckmann A; Planque M; Fendt SM; Vermeulen P; Ghadimi M; Kalucka J; De Oliveira T; Conradi LC
Mol Cancer; 2023 Jan; 22(1):17. PubMed ID: 36691028
[TBL] [Abstract][Full Text] [Related]
11. Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models.
Bridgeman VL; Vermeulen PB; Foo S; Bilecz A; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedus B; Hoetzenecker K; Renyi-Vamos F; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku S; Kerbel RS; Dome B; Reynolds AR
J Pathol; 2017 Feb; 241(3):362-374. PubMed ID: 27859259
[TBL] [Abstract][Full Text] [Related]
12. [The role of liver-specific contrast-enhanced MRI before resection of colorectal liver metastases].
Dede K; Kátai T; Demjén B; Nagy Z; Egyed T; Varga M; Egyed Z; Bursics A
Orv Hetil; 2021 Dec; 162(50):2010-2016. PubMed ID: 34896985
[TBL] [Abstract][Full Text] [Related]
13. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy.
Palmieri V; Lazaris A; Mayer TZ; Petrillo SK; Alamri H; Rada M; Jarrouj G; Park WY; Gao ZH; McDonald PP; Metrakos P
J Pathol; 2020 Jun; 251(2):213-223. PubMed ID: 32297656
[TBL] [Abstract][Full Text] [Related]
14. Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases.
Rada M; Kapelanski-Lamoureux A; Petrillo S; Tabariès S; Siegel P; Reynolds AR; Lazaris A; Metrakos P
Commun Biol; 2021 Aug; 4(1):950. PubMed ID: 34376784
[TBL] [Abstract][Full Text] [Related]
15. An Analysis of Clinicopathological Outcomes and the Utility of Preoperative MRI for Patients Undergoing Resection of Mucinous and Non-Mucinous Colorectal Cancer Liver Metastases.
Reynolds IS; Cromwell PM; Ryan ÉJ; McGrath E; Kennelly R; Ryan R; Swan N; Sheahan K; Winter DC; Hoti E
Front Oncol; 2022; 12():821159. PubMed ID: 35265523
[TBL] [Abstract][Full Text] [Related]
16. L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastases.
Barnhill R; van Laere S; Vermeulen P; Roman-Roman S; Gardrat S; Alsafadi S; Tarin M; Champenois G; Nicolas A; Matet A; Cassoux N; Servois V; Rodrigues M; Scolyer R; Lazar A; Romano E; Piperno-Neumann S; Mariani P; Lugassy C
Lab Invest; 2022 Nov; 102(11):1214-1224. PubMed ID: 35672380
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
[TBL] [Abstract][Full Text] [Related]
18. Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers.
Lau LF; Murone C; Williams DS; Standish R; Lee ST; Christophi C; Scott AM; Muralidharan V
ANZ J Surg; 2018 Mar; 88(3):E108-E113. PubMed ID: 27452367
[TBL] [Abstract][Full Text] [Related]
19. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
Frentzas S; Simoneau E; Bridgeman VL; Vermeulen PB; Foo S; Kostaras E; Nathan M; Wotherspoon A; Gao ZH; Shi Y; Van den Eynden G; Daley F; Peckitt C; Tan X; Salman A; Lazaris A; Gazinska P; Berg TJ; Eltahir Z; Ritsma L; Van Rheenen J; Khashper A; Brown G; Nystrom H; Sund M; Van Laere S; Loyer E; Dirix L; Cunningham D; Metrakos P; Reynolds AR
Nat Med; 2016 Nov; 22(11):1294-1302. PubMed ID: 27748747
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.
Hayashi M; Inoue Y; Komeda K; Shimizu T; Asakuma M; Hirokawa F; Miyamoto Y; Okuda J; Takeshita A; Shibayama Y; Tanigawa N
BMC Surg; 2010 Sep; 10():27. PubMed ID: 20875094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
